Trials / Completed
CompletedNCT00946491
To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
An Open-Label, Single-Dose, Crossover Study to Determine the Bioequivalency of Generic Haloperidol Tablets vs. Haldol in Normal Volunteers.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 35 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioequivalency of generic Haloperidol tablets versus Haldol in normal volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Haloperidol 10 mg Tablets (Cord Laboratories) | |
| DRUG | Haldol 10 mg Tablets (McNeil Pharmaceuticals) |
Timeline
- Start date
- 1987-04-01
- Primary completion
- 1987-05-01
- Completion
- 1987-05-01
- First posted
- 2009-07-27
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00946491. Inclusion in this directory is not an endorsement.